These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33928149)

  • 1. Admission Serum Ionized and Total Calcium as New Predictors of Mortality in Patients with Cardiogenic Shock.
    Yu Y; Yu J; Yao R; Wang P; Zhang Y; Xiao J; Wang Z
    Biomed Res Int; 2021; 2021():6612276. PubMed ID: 33928149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Neutrophil Percentage-to-Albumin Ratio as a New Predictor of All-Cause Mortality in Patients with Cardiogenic Shock.
    Yu Y; Liu Y; Ling X; Huang R; Wang S; Min J; Xiao J; Zhang Y; Wang Z
    Biomed Res Int; 2020; 2020():7458451. PubMed ID: 33294452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum total and ionized calcium with all-cause mortality incritically ill patients with acute kidney injury.
    Wang B; Li D; Gong Y; Ying B; Cheng B
    Clin Chim Acta; 2019 Jul; 494():94-99. PubMed ID: 30890398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
    Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
    Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte and its Subtypes as Predictors of Short-Term Outcome in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Cohort Study.
    Sasmita BR; Zhu Y; Gan H; Hu X; Xue Y; Xiang Z; Liu G; Luo S; Huang B
    Shock; 2022 Mar; 57(3):351-359. PubMed ID: 34710884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock.
    Wigger O; Bloechlinger S; Berger D; Häner J; Zanchin T; Windecker S; Räber L; Schefold JC
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):45-52. PubMed ID: 28838261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil Gelatinase-Associated Lipocalin (NGAL) Measured at Admission is Associated With Development of Late Cardiogenic Shock and Mortality in Patients With ST-Segment Elevation Myocardial Infarction.
    Frydland M; Møgelvang R; Møller JE; Helgestad OKL; Holmvang L; Mark PD; Jensen LO; Hassager C
    Shock; 2021 Aug; 56(2):255-259. PubMed ID: 34276039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. J-curve relationship between admission SBP and 2-year cardiovascular mortality in older patients admitted for acute coronary syndrome.
    Jiang C; Wu S; Wang M; Zhao X; Li H
    J Hypertens; 2021 May; 39(5):926-934. PubMed ID: 33201050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial Infarction.
    Klein A; Wiberg S; Hassager C; Winther-Jensen M; Frikke-Schmidt R; Bang LE; Lindholm MG; Holmvang L; Moeller-Helgestad O; Ravn HB; Jensen LO; Kjaergaard J; Moeller JE; Frydland M
    Shock; 2020 Mar; 53(3):299-306. PubMed ID: 31058719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock.
    Shaefi S; O'Gara B; Kociol RD; Joynt K; Mueller A; Nizamuddin J; Mahmood E; Talmor D; Shahul S
    J Am Heart Assoc; 2015 Jan; 4(1):e001462. PubMed ID: 25559014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of Serum Calcium in the Risk Stratification of Midterm Mortality among Patients with Acute Coronary Syndrome.
    Gu X; Ding X; Sun H; Chen N; Liu D; Sun D; Wang S
    Biomed Res Int; 2019; 2019():9542054. PubMed ID: 31781656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red Blood Cell Distribution Width Is Associated with All-Cause Mortality in Critically Ill Patients with Cardiogenic Shock.
    Wang B; Aihemaiti G; Cheng B; Li X
    Med Sci Monit; 2019 Sep; 25():7005-7015. PubMed ID: 31530796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between low-density lipoprotein cholesterol level and mortality in patients with cardiogenic shock: a retrospective cohort study.
    Jin J; Shi Z; Pang X
    BMJ Open; 2021 Jul; 11(7):e044668. PubMed ID: 34215599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Initial Serum Total Calcium Concentration with Mortality in Critical Illness.
    Wang B; Gong Y; Ying B; Cheng B
    Biomed Res Int; 2018; 2018():7648506. PubMed ID: 30046608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Albumin Predict the Risk of Mortality in Patients with Cardiogenic Shock?
    Schupp T; Behnes M; Rusnak J; Ruka M; Dudda J; Forner J; Egner-Walter S; Barre M; Abumayyaleh M; Bertsch T; Müller J; Akin I
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock - Results from the CardShock Study.
    Kataja A; Tarvasmäki T; Lassus J; Cardoso J; Mebazaa A; Køber L; Sionis A; Spinar J; Carubelli V; Banaszewski M; Marino R; Parissis J; Nieminen MS; Harjola VP
    Int J Cardiol; 2017 Jan; 226():48-52. PubMed ID: 27788389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic iron in acute myocardial infarction complicated by cardiogenic shock - A biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Traeder F; Lele SS; Rajapurkar MM; Mukhopadhyay B; de Waha S; Desch S; Eitel I; Schuler G; Adams V; Thiele H
    Int J Cardiol; 2017 Jan; 227():83-88. PubMed ID: 27865117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of hyperlactatemia on admission in critically ill patients with acute myocardial infarction: A retrospective study from MIMIC-IV.
    Lu T; Tan L; Xu K; Liu J; Liu C; Zhang G; Shi R; Huang Z
    Front Endocrinol (Lausanne); 2022; 13():1015298. PubMed ID: 36213274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction.
    Andrié RP; Becher UM; Frommold R; Tiyerili V; Schrickel JW; Nickenig G; Schwab JO
    Crit Care; 2012 Aug; 16(4):R152. PubMed ID: 22889197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating angiopoietins and cardiovascular mortality in cardiogenic shock.
    Link A; Pöss J; Rbah R; Barth C; Feth L; Selejan S; Böhm M
    Eur Heart J; 2013 Jun; 34(22):1651-62. PubMed ID: 23349297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.